BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement Surgery
NCT02170701
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
289
Enrollment
INDUSTRY
Sponsor class
Conditions
Venous Thromboembolism
Interventions
DRUG:
BIBR 1048
Sponsor
Boehringer Ingelheim